Link Pharma Chem (BOM:524748) Cyclically Adjusted Revenue per Share: ₹84.63 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524748 Link Pharma Chem Ltd BOM:524748
61 GF Score
Price ₹28.00
GF Value ₹36.75
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Link Pharma Chem Cyclically Adjusted Revenue per Share?

Link Pharma Chem BOM:524748 61 Cyclically Adjusted Revenue per Share is ₹84.63 as of Jun. 2026. GuruFocus rates BOM:524748 with a GF Score™ of 61/100 and a GF Value™ of ₹36.75 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Link Pharma Chem's adjusted revenue per share for the three months ended in Jun. 2026 was ₹19.834. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹84.63 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Link Pharma Chem's average Cyclically Adjusted Revenue Growth Rate was 6.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Link Pharma Chem was 7.30% per year. The lowest was 3.10% per year. And the median was 3.80% per year.

As of today (2026-08-27), Link Pharma Chem's current stock price is ₹28.00. Link Pharma Chem's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹84.63. Link Pharma Chem's Cyclically Adjusted PS Ratio of today is 0.33.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Link Pharma Chem was 0.95. The lowest was 0.28. And the median was 0.53.


Link Pharma Chem  (BOM:524748) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Link Pharma Chem's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=28.00/84.63
=0.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Link Pharma Chem was 0.95. The lowest was 0.28. And the median was 0.53.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Link Pharma Chem Cyclically Adjusted Revenue per Share Related Terms


Link Pharma Chem Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Link Pharma Chem's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Link Pharma Chem Cyclically Adjusted Revenue per Share Chart

Link Pharma Chem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.81 75.46 76.45 77.99 82.61

Link Pharma Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.53 81.19 82.18 82.61 84.63

BOM:524748 vs DOW: Cyclically Adjusted Revenue per Share Comparison

For the Chemicals subindustry, Link Pharma Chem's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Link Pharma Chem Cyclically Adjusted PS Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Link Pharma Chem's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Link Pharma Chem's Cyclically Adjusted PS Ratio falls into.


BOM:524748
61GF Score
Link Pharma Chem Ltd BOM:524748
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Link Pharma Chem Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Link Pharma Chem's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=19.834/167.3573*167.3573
=19.834

Current CPI (Jun. 2026) = 167.3573.

Link Pharma Chem Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 8.311 105.961 13.127
201612 8.627 105.196 13.725
201703 8.623 105.196 13.718
201706 14.265 107.109 22.289
201709 12.687 109.021 19.476
201712 14.317 109.404 21.901
201803 12.023 109.786 18.328
201806 12.318 111.317 18.519
201809 19.756 115.142 28.715
201812 13.117 115.142 19.065
201903 9.524 118.202 13.485
201906 12.502 120.880 17.309
201909 13.979 123.175 18.993
201912 16.529 126.235 21.913
202003 13.193 124.705 17.705
202006 11.464 127.000 15.107
202009 21.126 130.118 27.172
202012 22.379 130.889 28.614
202103 25.367 131.771 32.218
202106 30.126 134.084 37.602
202109 33.454 135.847 41.214
202112 31.572 138.161 38.244
202203 25.450 138.822 30.681
202206 26.244 142.347 30.855
202209 19.035 144.661 22.021
202212 20.887 145.763 23.981
202303 20.884 146.865 23.798
202306 17.708 150.280 19.720
202309 13.626 151.492 15.053
202312 17.946 152.924 19.640
202403 18.161 153.035 19.861
202406 19.996 155.789 21.481
202409 10.809 157.882 11.458
202412 12.013 158.323 12.698
202503 14.542 157.552 15.447
202506 17.697 159.755 18.539
202509 12.102 162.289 12.480
202512 14.811 163.281 15.181
202603 14.836 164.272 15.115
202606 19.834 167.357 19.834

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹84.63 mean?
Link Pharma Chem (BOM:524748) has a Cyclically Adjusted Revenue per Share of ₹84.63 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Link Pharma Chem and its competitors.
Is Link Pharma Chem's Cyclically Adjusted Revenue per Share too high?
Link Pharma Chem's current Cyclically Adjusted Revenue per Share is ₹84.63. Overall, Link Pharma Chem has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Link Pharma Chem's Cyclically Adjusted Revenue per Share compare to DOW?
Link Pharma Chem's Cyclically Adjusted Revenue per Share of ₹84.63 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Chemicals company?
A good Cyclically Adjusted Revenue per Share depends on the Chemicals industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Link Pharma Chem and its competitors. Link Pharma Chem's current Cyclically Adjusted Revenue per Share is ₹84.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Link Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Link Pharma Chem (BOM:524748) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹36.75, compared to a current price of ₹28.00 — trading 23.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹84.63. Link Pharma Chem's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Link Pharma Chem (BOM:524748), the current Cyclically Adjusted Revenue per Share is ₹84.63 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Link Pharma Chem (BOM:524748) Overvalued in 2026?

Based on GuruFocus' analysis, Link Pharma Chem stock appears to be undervalued. The current stock price of ₹28.00 is trading 23.8% below its estimated GF Value™ of ₹36.75. GuruFocus considers Link Pharma Chem to be Modestly Undervalued.

Key valuation signals for BOM:524748:

  • Cyclically Adjusted Revenue per Share: ₹84.63
  • GF Value™: ₹36.75 vs. price of ₹28.00 (23.8% below fair value)
  • GF Score™: 61/100 with 2 warning signs

No single metric tells the full story. See the BOM:524748 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Link Pharma Chem Business Description

Address Plot No. 161/1, 162, G.I.D.C, Nandesari Industrial Estate, Nandesari, Vadodara, GJ, IND, 391 340
Link Pharma Chem Ltd is engaged in the manufacturing and selling of organic intermediates which are used in pharmaceuticals, agro and speciality chemical industries. The company has its manufacturing location at Nandesari in Gujarat. It operates through single segment which is Chemical manufacturing and generates revenue from the same. The company generates the majority of its revenue from domestic sales.
61GF Score

Get the complete analysis for BOM:524748

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹28.00
Price
₹36.75
GF Value